Company / Revenue per Share
Immunome Inc. Revenue per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.11
FY2025
5-year range
$0.11 / $1.16
FY2023-FY2025
Trend
-66.8%
vs FY2024
Sector context
#132 of 154
Health Care
What the data says
Immunome Inc.'s revenue per share of $0.11 is lower than 86% of companies in the Health Care sector (FY2025). Declined from $1.16 to $0.11 over the past 2 years.
Based on SEC 10-K filings.
0.11 in FY2025.
Declined from $1.16 to $0.11 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 154This company $0.11 Sector average $10.35
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 66.8% year-over-year.
- Ranks #132 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | -66.8% |
| FY2024 | $0.32 | -72.0% |
| FY2023 | $1.16 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026